Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies.

He XF, Wei W, Li JL, Shen XL, Ding DP, Wang SL, Liu ZZ, Qin JB, Wu LX, Xie DL.

Gene. 2013 Jul 1;523(1):10-9. doi: 10.1016/j.gene.2013.03.071. Epub 2013 Apr 2.

PMID:
23562721
2.

Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies.

Huang G, Cai S, Wang W, Zhang Q, Liu A.

PLoS One. 2013 Aug 26;8(8):e68457. doi: 10.1371/journal.pone.0068457. eCollection 2013.

3.

Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.

He XF, Wei W, Su J, Yang ZX, Liu Y, Zhang Y, Ding DP, Wang W.

Mol Biol Rep. 2012 May;39(5):5125-34. doi: 10.1007/s11033-011-1308-y. Epub 2011 Dec 10.

PMID:
22161248
4.

Meta-analysis of the relationship between XRCC3 T241M polymorphism and colorectal cancer susceptibility.

Zhang LZ, Li YS, Liu HZ.

Genet Mol Res. 2015 Nov 23;14(4):14831-9. doi: 10.4238/2015.November.18.48.

5.

XRCC3 T241M polymorphism and lung cancer risk in the Han Chinese population: a meta-analysis.

Zhang JH, Wen QL, Yang C, Li AL, Liu Y, Li XS.

Genet Mol Res. 2014 Nov 11;13(4):9505-13. doi: 10.4238/2014.November.11.15.

6.

XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis.

Sun H, Qiao Y, Zhang X, Xu L, Jia X, Sun D, Shen C, Liu A, Zhao Y, Jin Y, Yu Y, Bai J, Fu S.

Cancer Sci. 2010 Aug;101(8):1777-82. doi: 10.1111/j.1349-7006.2010.01608.x. Epub 2010 Apr 29.

7.
8.

XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis.

Li F, Li C, Jiang Z, Ma N, Gao X.

Urology. 2011 Feb;77(2):511.e1-5. doi: 10.1016/j.urology.2010.07.003. Epub 2010 Oct 13.

PMID:
20947146
9.

DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies.

Han S, Zhang HT, Wang Z, Xie Y, Tang R, Mao Y, Li Y.

Eur J Hum Genet. 2006 Oct;14(10):1136-44. Epub 2006 Jun 21.

10.

XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.

Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC.

Breast Cancer Res Treat. 2010 Jul;122(2):489-93. doi: 10.1007/s10549-009-0726-1. Epub 2010 Jan 5. Review.

PMID:
20049524
11.

Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.

Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):583-91.

12.
13.

XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis.

Fan J, Fan Y, Kang X, Zhao L.

Oncol Lett. 2015 May;9(5):2425-2429. Epub 2015 Mar 16.

14.

Association between the CYP1A1 T3801C polymorphism and risk of cancer: evidence from 268 case-control studies.

He XF, Wei W, Liu ZZ, Shen XL, Yang XB, Wang SL, Xie DL.

Gene. 2013 Oct 24. pii: S0378-1119(13)01420-0. doi: 10.1016/j.gene.2013.10.025. [Epub ahead of print]

PMID:
24513335
15.

DNA repair gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese population.

Zhu X, Zhong Z, Zhang X, Zhao X, Xu R, Ren W, Li S.

Genet Test Mol Biomarkers. 2012 Jun;16(6):640-3. doi: 10.1089/gtmb.2011.0334. Epub 2012 Feb 2.

PMID:
22299591
16.

Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Feng YZ, Liu YL, He XF, Wei W, Shen XL, Xie DL.

Tumour Biol. 2014 Nov;35(11):10677-97. doi: 10.1007/s13277-014-2326-x. Epub 2014 Jul 27.

PMID:
25064613
17.

XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis.

Economopoulos KP, Sergentanis TN.

Breast Cancer Res Treat. 2010 Jun;121(2):439-43. doi: 10.1007/s10549-009-0562-3. Epub 2009 Sep 30.

PMID:
19789975
18.

GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis.

Hu J, Zhou GW, Wang N, Wang YJ.

Breast Cancer Res Treat. 2010 Nov;124(2):425-31. doi: 10.1007/s10549-010-0841-z. Epub 2010 Mar 21.

PMID:
20306294
19.

DNA repair gene XRCC3 Thr241Met polymorphisms and lung cancer risk: a meta-analysis.

Bei L, Xiao-Dong T, Yu-Fang G, Jian-Ping S, Zhao-Yu Y.

Bull Cancer. 2015 Apr;102(4):332-9. doi: 10.1016/j.bulcan.2015.02.003. Epub 2015 Mar 17. Review.

PMID:
25794597
20.

Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis.

Fang F, Wang J, Yao L, Yu XJ, Yu L, Yu L.

Med Oncol. 2011 Dec;28(4):999-1003. doi: 10.1007/s12032-010-9591-3. Epub 2010 Jun 12.

PMID:
20549576

Supplemental Content

Support Center